March 3, 2025 · Form 4 insider transaction
Rothfuss Cristin sold 391 shares of Sarepta Therapeutics, Inc. at $103.77 per share, a transaction worth $40.6K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024.; Amount of Securities Beneficially Owned includes 195 shares purchased under the Company's registered Employee Stock Purchase Plan on February 28, 2025.